Trinity Life Sciences is a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech to advance the development, launch, and optimization of new medical innovations. Founded in 1996, the firm has been involved in an estimated 70% of all new drug launches and works with over 350 industry-leading customers globally.
The company's work is centered on technical domains including artificial intelligence, analytics, and real-world evidence. It has developed proprietary technology platforms such as TrinityEDGE™ and InsightsEDGE™ to support life sciences commercialization efforts. Its capabilities include the ability to predict up to 90% of revenue outcomes for clients.
Trinity Life Sciences maintains a global presence, operating across North America, Europe, Latin America, and Asia Pacific. Its focus is on providing data-driven strategy and execution to support the commercial lifecycle of medical innovations across its core industry verticals.
